Derek Archila
Stock Analyst at Wells Fargo
(4.90)
# 267
Out of 4,690 analysts
933
Total ratings
57.7%
Success rate
22.1%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Rated: Buy | $116 → $151 | $118.15 | +27.80% | 25 | Aug 27, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,350 → $1,415 | $1,023.21 | +38.29% | 79 | Aug 26, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $326 | $247.91 | +31.50% | 45 | Aug 14, 2026 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $12 | $3.23 | +271.52% | 2 | Aug 14, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | $33 | $8.37 | +294.27% | 14 | Aug 14, 2026 | |
| ALMS Alumis | Reiterated: Buy | $51 | $22.38 | +127.88% | 10 | Aug 14, 2026 | |
| ANNX Annexon | Reiterated: Buy | $27 | $4.97 | +443.26% | 22 | Aug 13, 2026 | |
| CCCC C4 Therapeutics | Rated: Buy | $10 | $3.85 | +159.74% | 14 | Aug 12, 2026 | |
| SEPN Septerna | Reiterated: Buy | $48 → $50 | $38.91 | +28.50% | 13 | Aug 12, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $98 → $102 | $76.60 | +33.16% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 | $0.54 | +85.19% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 | $39.12 | +84.05% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $116 | $124.37 | -6.73% | 41 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $59 | $15.03 | +292.55% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $11 | $9.18 | +19.83% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $13.24 | +88.82% | 13 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $55 | $41.86 | +31.39% | 3 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 | $23.08 | +34.32% | 19 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $107.17 | +44.63% | 61 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $26.21 | -4.62% | 24 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.04 | +172.28% | 1 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $13.38 | +116.74% | 17 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $41.20 | +9.22% | 29 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.00 | +150.00% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $79 | $80.03 | -1.29% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $35 | $54.45 | -35.72% | 26 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $479 → $376 | $237.10 | +58.58% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $56 | $68.91 | -18.73% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $81 | $56.28 | +43.92% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 | $70.09 | +4.15% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $35.62 | +183.55% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $67.69 | -54.20% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $30 | $20.45 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $2 | $3.12 | n/a | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $28.27 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $3.80 | n/a | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $60.43 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.13 | $1.40 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $2.39 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.3266 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $9.60 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $43.62 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $28.74 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $533.76 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $13.54 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $13.97 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $32.16 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €15.54 → €16.40 | €4.00 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $4.71 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €285.69 → €287.41 | €909.40 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €90.63 → €96.00 | €25.02 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | €14.38 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.76 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.29 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $11.57 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.001 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $14.48 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.44 | n/a | 18 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.06 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.34 | n/a | 1 | Oct 3, 2017 |
Kymera Therapeutics
Aug 27, 2026
Rated: Buy
Price Target: $116 → $151
Current: $118.15
Upside: +27.80%
argenx SE
Aug 26, 2026
Rated: Buy
Price Target: $1,350 → $1,415
Current: $1,023.21
Upside: +38.29%
Ascendis Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $326
Current: $247.91
Upside: +31.50%
Pyxis Oncology
Aug 14, 2026
Reiterated: Buy
Price Target: $12
Current: $3.23
Upside: +271.52%
Kyverna Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $33
Current: $8.37
Upside: +294.27%
Alumis
Aug 14, 2026
Reiterated: Buy
Price Target: $51
Current: $22.38
Upside: +127.88%
Annexon
Aug 13, 2026
Reiterated: Buy
Price Target: $27
Current: $4.97
Upside: +443.26%
C4 Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $10
Current: $3.85
Upside: +159.74%
Septerna
Aug 12, 2026
Reiterated: Buy
Price Target: $48 → $50
Current: $38.91
Upside: +28.50%
BridgeBio Pharma
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $102
Current: $76.60
Upside: +33.16%
Aug 10, 2026
Rated: Hold
Price Target: $1
Current: $0.54
Upside: +85.19%
Aug 6, 2026
Reiterated: Buy
Price Target: $72
Current: $39.12
Upside: +84.05%
Aug 6, 2026
Maintained: Hold
Price Target: $116
Current: $124.37
Upside: -6.73%
Aug 6, 2026
Reiterated: Buy
Price Target: $66 → $59
Current: $15.03
Upside: +292.55%
Aug 5, 2026
Downgraded: Hold
Price Target: $15 → $11
Current: $9.18
Upside: +19.83%
Aug 4, 2026
Maintained: Buy
Price Target: $25
Current: $13.24
Upside: +88.82%
Jul 28, 2026
Reiterated: Buy
Price Target: $30 → $55
Current: $41.86
Upside: +31.39%
Jul 20, 2026
Rated: Buy
Price Target: $31
Current: $23.08
Upside: +34.32%
Jul 16, 2026
Rated: Buy
Price Target: $155
Current: $107.17
Upside: +44.63%
Jul 14, 2026
Maintained: Hold
Price Target: $25
Current: $26.21
Upside: -4.62%
Jul 10, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $4.04
Upside: +172.28%
Jun 24, 2026
Rated: Buy
Price Target: $29
Current: $13.38
Upside: +116.74%
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $41.20
Upside: +9.22%
Mar 19, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Mar 2, 2026
Maintained: Buy
Price Target: $78 → $79
Current: $80.03
Upside: -1.29%
Feb 11, 2026
Maintained: Hold
Price Target: $30 → $35
Current: $54.45
Upside: -35.72%
Jan 20, 2026
Maintained: Hold
Price Target: $479 → $376
Current: $237.10
Upside: +58.58%
Dec 16, 2025
Maintained: Sell
Price Target: $56
Current: $68.91
Upside: -18.73%
Dec 16, 2025
Maintained: Buy
Price Target: $51 → $81
Current: $56.28
Upside: +43.92%
Oct 17, 2025
Maintained: Buy
Price Target: $73
Current: $70.09
Upside: +4.15%
Oct 17, 2025
Maintained: Buy
Price Target: $101
Current: $35.62
Upside: +183.55%
Oct 17, 2025
Maintained: Buy
Price Target: $31
Current: $67.69
Upside: -54.20%
Aug 12, 2025
Maintained: Hold
Price Target: $40 → $30
Current: $20.45
Upside: n/a
Aug 8, 2025
Maintained: Hold
Price Target: $3 → $2
Current: $3.12
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $14
Current: $28.27
Upside: n/a
Aug 6, 2025
Maintained: Hold
Price Target: $6 → $5
Current: $3.80
Upside: n/a
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $60.43
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.13
Current: $1.40
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $2.39
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.3266
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $9.60
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $43.62
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $28.74
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $533.76
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $13.54
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $13.97
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $32.16
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €15.54 → €16.40
Current: €4.00
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $4.71
Upside: n/a
Mar 4, 2021
Maintained: Hold
Price Target: €285.69 → €287.41
Current: €909.40
Upside: n/a
Feb 19, 2021
Maintained: Hold
Price Target: €90.63 → €96.00
Current: €25.02
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: €14.38
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $25.76
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $5.29
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $11.57
Upside: n/a
Mar 22, 2018
Maintained: Buy
Price Target: n/a
Current: $0.001
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $14.48
Upside: n/a
Feb 8, 2018
Rated: Hold
Price Target: n/a
Current: $36.44
Upside: n/a
Nov 9, 2017
Maintained: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Oct 3, 2017
Maintained: Hold
Price Target: n/a
Current: $16.34
Upside: n/a